Barclays
DERM icon

Barclays’s Journey Medical DERM Stock Holding History

Barclays’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.5K Sell
2,324
-2,298
-50% -$13.1K ﹤0.01% 4620
2026
Q1 		$21.7K Sell
4,622
-17,899
-79% -$139K ﹤0.01% 4563
2025
Q4 		$174K Buy
22,521
+4,955
+28% +$38.9K ﹤0.01% 4397
2025
Q3 		$125K Sell
17,566
-4,837
-22% -$35.1K ﹤0.01% 4544
2025
Q2 		$161K Buy
+22,403
New +$155K ﹤0.01% 4392

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Barclays's DERM Position: Q2 2026 in Review

Barclays reduced its Journey Medical (DERM) stake by 50% in Q2 2026, selling an estimated $13.1K and leaving 2,324 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4620.

Barclays first reported a position in DERM in Q2 2025 and has held it in 5 quarters since. The position peaked at $174K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Barclays held 2,324 shares of Journey Medical worth $16.5K as of Q2 2026.
  • Barclays sold 2,298 Journey Medical shares in Q2 2026, an estimated $13.1K.
  • Journey Medical made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4620 holding.
  • Barclays first reported a position in Journey Medical in Q2 2025 and has held it in 5 quarters since.
  • Barclays's Journey Medical position peaked at $174K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.